McN-5558

From Wikipedia, the free encyclopedia

PubChem CID
FormulaC19H18F3N
McN-5558
Identifiers
  • (6S,10bR)-6-[3-(trifluoromethyl)phenyl]-1,2,3,5,6,10b-hexahydropyrrolo[2,1-a]isoquinoline
PubChem CID
ChemSpider
ChEMBL
Chemical and physical data
FormulaC19H18F3N
Molar mass317.355 g·mol−1
3D model (JSmol)
  • C1C[C@@H]2C3=CC=CC=C3[C@@H](CN2C1)C4=CC(=CC=C4)C(F)(F)F
  • InChI=1S/C19H18F3N/c20-19(21,22)14-6-3-5-13(11-14)17-12-23-10-4-9-18(23)16-8-2-1-7-15(16)17/h1-3,5-8,11,17-18H,4,9-10,12H2/t17-,18+/m0/s1
  • Key:LWXKKDYZAXBAPH-ZWKOTPCHSA-N

McN-5558 is a drug which acts as a selective noradrenaline reuptake inhibitor. It was investigated for potential application as an antidepressant, but was never developed for clinical use.[1][2]

McN-5558 is described as a serotonin–norepinephrine reuptake inhibitor (SNRI) with equilibrium constants (Kis) for various neurotransmitter transporters:[2]

Compound 37b norepinephrine transporter
(NE)
dopamine transporter
(DAT)
serotonin transporter
(SERT)
racemic 1.0 54.3 23.0
(+) 1.5 25.7 9.1
(-) 2570 7690 2920

These data show that virtually all of the binding affinities resides in a single enantiomer. Consequently, the compound displays a very high eudysmic ratio.

SAR

See also

References

Related Articles

Wikiwand AI